Related Experiment Video
Updated: Oct 9, 2025

05:36
Author Spotlight: Assessing the Impact of Novel Iron Chelators on Cancer Cell Metabolism
Published on: February 23, 2024
614
Iron in Cardiovascular Disease: Challenges and Potentials.
1Department of Geriatrics, The Second Xiangya Hospital, Central South University, Changsha, China.
Frontiers in Cardiovascular Medicine
|December 17, 2021
Summary
Iron
Area of Science:
- Cardiovascular Research
- Cell Death Mechanisms
- Mineral Metabolism
Background:
- Iron is vital for biological functions, but imbalances cause disease.
- Iron's role in cardiovascular disease (CVD) is complex and not fully understood.
- Ferroptosis, an iron-dependent cell death, is implicated in various CVDs.
Purpose of the Study:
- To review the pathological roles of iron in cardiovascular diseases.
- To highlight ferroptosis as a key mechanism in iron-related CVD.
- To discuss iron chelation therapy for cardiovascular conditions.
Main Methods:
- Literature review and synthesis of existing research on iron metabolism and CVD.
- Analysis of studies investigating ferroptosis in cardiovascular conditions.
- Evaluation of therapeutic strategies targeting iron overload.
Main Results:
- Iron deficiency negatively impacts heart failure and pulmonary arterial hypertension.
- Ferroptosis is observed in cardiomyopathy, atherosclerosis, and ischemia/reperfusion injury.
- Iron chelation shows potential for treating iron overload disorders.
Conclusions:
- Clarifying iron's precise role in CVD is crucial for developing effective treatments.
- Targeting ferroptosis may offer novel therapeutic avenues for cardiovascular diseases.
- Further research is needed to optimize iron-related interventions in CVD.
Related Concept Videos
Coronary Artery Disease I: Introduction
470
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
470
Regulation of the Cardiovascular System
2.2K
The regulation of the cardiovascular system allows the body to adapt to various demands and maintain homeostasis.
The regulation of the cardiovascular system involves the autonomic nervous system (ANS), baroreceptors, and chemoreceptors, ensuring that heart rate and blood pressure are appropriately modulated in response to varying physiological demands.
The ANS comprises two main divisions: the sympathetic and parasympathetic nervous systems. The sympathetic nervous system enhances...
The regulation of the cardiovascular system involves the autonomic nervous system (ANS), baroreceptors, and chemoreceptors, ensuring that heart rate and blood pressure are appropriately modulated in response to varying physiological demands.
The ANS comprises two main divisions: the sympathetic and parasympathetic nervous systems. The sympathetic nervous system enhances...
2.2K
Ischemic Heart Disease: Overview
1.9K
Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
1.9K
Cardiovascular Drugs: Classification based on Therapeutic Indications
3.4K
Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
3.4K
Pathophysiology of Cardiac Performance
872
Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
872
Atherosclerosis III: Management
62
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
62

